AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 284: H876-H883, 2003. First published November 7, 2002; doi:10.1152/ajpheart.00266.2002
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/3/H876    most recent
00266.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishra, S.
Right arrow Articles by Gupta, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishra, S.
Right arrow Articles by Gupta, R. C.
Vol. 284, Issue 3, H876-H883, March 2003

Reduced Ca2+-calmodulin-dependent protein kinase activity and expression in LV myocardium of dogs with heart failure

Sudhish Mishra1, Hani N. Sabbah1, Jinesh C. Jain2, and Ramesh C. Gupta1

1 Division of Cardiovascular Medicine, Department of Medicine, Henry Ford Heart and Vascular Institute, Detroit, Michigan 48202; and 2 Department of Civil Engineering and Geological Sciences, University of Notre Dame, Notre Dame, Indiana 46556

Studies on the status of multifunctional Ca2+-calmodulin (CaM)-dependent protein kinase-II (CaMKII) in failing hearts are limited and controversial. The study was performed in the left ventricular (LV) myocardium of six dogs with heart failure (HF) (LV ejection fraction, 23 ± 2%) and six normal (NL) dogs. In the LV homogenate, CaMKII activity and its protein level were determined by using the CaMKII peptide and antibody, respectively. Furthermore, the protein level of CaM and phosphorylated phospholamban (PLB) at threonine-17 (PLB-Thr17) and serine-16 (PLB-Ser16) were also determined in the LV homogenate using a specific antibody. In addition, the level of zinc, which inhibits protein kinase A activity, was determined in the LV tissue by inductively coupled plasma mass spectrometry. CaMKII activity and phosphorylated PLB-Thr17 and PLB-Ser16 levels, but not CaM and Zn levels, were significantly reduced in the LV homogenate of dogs with HF compared with NL dogs. These results suggest that CaMKII activity is reduced in the failing LV myocardium, and this abnormality is associated with reduced protein expression level of the enzyme but not due to changes in CaM and zinc levels. In conclusion, reduced CaMKII activity and phosphorylated PLB level may be partly responsible for impaired sarcoplasmic reticulum function in HF.

phospholamban; phosphorylation; zinc


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. H. Little, A. Saw, Y. Bai, J. Dow, P. Marjoram, B. Simkhovich, J. Leeka, L. Kedes, R. A. Kloner, and C. Poizat
Critical Role of Nuclear Calcium/Calmodulin-dependent Protein Kinase II{delta}B in Cardiomyocyte Survival in Cardiomyopathy
J. Biol. Chem., September 11, 2009; 284(37): 24857 - 24868.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Yu, Z.-H. Wang, and H.-T. Yang
Calcium/calmodulin-dependent protein kinase II mediates cardioprotection of intermittent hypoxia against ischemic-reperfusion-induced cardiac dysfunction
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H735 - H742.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
Y. Ikeda, M. Hoshijima, and K. R. Chien
Toward Biologically Targeted Therapy of Calcium Cycling Defects in Heart Failure
Physiology, February 1, 2008; 23(1): 6 - 16.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Liu, R. B. Marchase, and J. C. Chatham
Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1391 - H1399.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh
Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation
Physiol Rev, April 1, 2007; 87(2): 425 - 456.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Mattiazzi, C. Mundina-Weilenmann, C. Guoxiang, L. Vittone, and E. Kranias
Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions
Cardiovasc Res, December 1, 2005; 68(3): 366 - 375.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Rocchetti, A. Besana, G. Mostacciuolo, R. Micheletti, P. Ferrari, S. Sarkozi, C. Szegedi, I. Jona, and A. Zaza
Modulation of Sarcoplasmic Reticulum Function by Na+/K+ Pump Inhibitors with Different Toxicity: Digoxin and PST2744 [(E,Z)-3-((2-Aminoethoxy)imino)androstane-6,17-dione Hydrochloride]
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 207 - 215.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. C. Gupta, S. Mishra, S. Rastogi, M. Imai, O. Habib, and H. N. Sabbah
Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2373 - H2381.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. N. Sabbah, V. G. Sharov, R. C. Gupta, S. Mishra, S. Rastogi, A. I. Undrovinas, P. A. Chaudhry, A. Todor, T. Mishima, E. J. Tanhehco, et al.
Reversal of Chronic Molecular and Cellular Abnormalities Due to Heart Failure by Passive Mechanical Ventricular Containment
Circ. Res., November 28, 2003; 93(11): 1095 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Afroze, L. L. Yang, C. Wang, R. Gros, W. Kalair, A. N. Hoque, I. N. Mungrue, Z. Zhu, and M. Husain
Calcineurin-independent regulation of plasma membrane Ca2+ ATPase-4 in the vascular smooth muscle cell cycle
Am J Physiol Cell Physiol, July 1, 2003; 285(1): C88 - C95.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online